Tag: Pbm

According to a survey by the National Community Pharmacists Association, 59% of independent pharmacists reported being subject to gag clauses before federal bans were enacted [1.4.1]. What is the gag clause for pharmacists? It was a contractual barrier preventing them from telling patients about cheaper drug options.

With over a quarter of U.S. adults finding it difficult to afford their medication, many wonder **why do pharmacies honor GoodRx?** The answer lies in a complex system of contracts, competition, and the drive for customer foot traffic [1.2.7].

Once the world's top-selling drug with peak annual sales exceeding $20 billion, Humira is experiencing a dramatic market shift [1.2.3, 1.5.7]. This article explores what is going on with Humira as its sales decline and a wave of biosimilar competitors enters the scene.

Group Purchasing Organizations (GPOs) reportedly save the U.S. healthcare system up to $55 billion annually. These vital, yet often misunderstood, entities define what is a GPO drug through their bulk purchasing contracts. In simple terms, a GPO drug is any pharmaceutical procured by a healthcare provider under the discounted terms negotiated by a GPO.

Nearly 85% of Americans have some form of prescription drug coverage, and for a vast number of these individuals, the pharmacy benefit is administered through a managed care organization (MCO) pharmacy. This system is a complex, behind-the-scenes operation designed to balance cost control and quality patient care. Understanding **what is an MCO pharmacy** is key to navigating your healthcare effectively.

An estimated 83% of independent pharmacies in the U.S. contracted with a Pharmacy Services Administrative Organization (PSAO) in 2019, highlighting their critical role in the complex healthcare landscape. This guide explains what is a PSAO, its essential functions, and how it empowers independent pharmacists to thrive in an increasingly competitive market.